Onyx Biotec Financials

NSE: ONYX

₹39.20

₹-0.70 (-1.75%)

As on 03-Sep-2026 13:44IST

Market cap

₹72 Cr

Revenue (TTM)

₹62 Cr

P/E Ratio

--

P/B Ratio

1.3

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Operating Revenue	61.95	53.75	39.48	44.86	--	--
Total Income	63.12	53.87	39.61	44.98	--	--
Total Expenditure	51.58	45.36	34.99	39.09	--	--
EBITDA	10.37	8.39	4.49	5.77	--	--
Depreciation	3.05	1.87	1.49	1.45	--	--
EBIT	7.33	6.52	3.00	4.32	--	--
Interest	2.02	2.16	0.57	0.65	--	--
Other Income	1.17	0.13	0.12	0.12	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	6.48	4.49	2.55	3.80	--	--
Provision for Tax	1.52	0.86	0.70	0.44	--	--
Profit after Tax	4.95	3.63	1.84	3.35	--	--

Liabilities (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Shareholder's Funds	55.62	25.29	18.20	16.38	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	9.90	26.30	20.31	10.43	--	--
Current Liabilities	25.73	22.55	20.21	10.03	--	--
Total Liabilities	91.25	74.14	58.72	36.84	--	--

Assets (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Non-Current Assets	42.06	44.58	44.16	22.41	--	--
Current Assets	49.19	29.56	14.56	14.43	--	--
Total Assets	91.25	74.14	58.72	36.84	--	--
Total Debt*	12.46	30.78	29.23	12.24	--	--
Net Current Assets	23.46	7.01	-5.64	4.40	--	--
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Cash From Operating Activities	1.42	1.52	6.24	0.49	--	--
Cash Flow from Investing Activities	0.66	-3.15	-22.67	-5.78	--	--
Cash from Financing Activities	5.07	3.09	16.43	5.20	--	--
Net Cash Inflow / Outflow	7.15	1.46	-0.01	-0.09	--	--

Financials Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Adjusted EPS (₹)	2.73	2.73	1.56	2.84	--	--
Cash EPS (₹)	4.41	4.13	2.83	4.07	--	--
Adjusted Book Value (₹)	30.68	18.98	15.42	13.87	--	--
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	0.78	1.14	10.57	0.82	--	--
Free Cash Flow per Share (₹)	-1.50	-3.57	-30.17	-10.91	--	--

Profitability Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
ROCE (%)	13.68	12.85	8.21	15.52	--	--
ROE (%)	12.25	16.71	10.67	20.47	--	--
ROA (%)	5.99	5.47	3.86	9.10	--	--
EBIT Margin (%)	11.83	12.13	7.59	9.64	--	--
Net Margin (%)	7.85	6.75	4.66	7.45	--	--
Cash Profit Margin (%)	12.92	10.24	8.45	10.70	--	--

Growth Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Revenue Growth (%)	15.26	36.14	-11.99	--	--	--
EBIT Growth (%)	12.34	117.62	-30.69	--	--	--
Net Profit Growth (%)	36.31	97.04	-44.98	--	--	--
EPS Growth (%)	0.15	74.57	-44.98	--	--	--
Book Value Growth (%)	119.96	38.93	11.15	--	--	--

Valuation Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Price / Earnings	21.23	--	--	--	--	--
Price / Book Value	1.89	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	9.45	5.01	7.61	3.08	--	--
Close Price (₹)	58.00	--	--	--	--	--
High Price (₹)	97.45	--	--	--	--	--
Low Price (₹)	51.00	--	--	--	--	--
Market Cap (₹ Cr)	105.17	--	--	--	--	--

Solvency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debt to Equity	0.22	1.22	1.61	0.75	--	--
Short term debt to equity ratio	0.07	0.12	0.40	0.08	--	--
Current Ratio	1.91	1.31	0.72	1.44	--	--
Quick Ratio	1.29	0.91	0.42	1.17	--	--
Interest Coverage	4.21	3.08	5.43	6.86	--	--

Operating Efficiency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debtors to sales (%)	32.66	28.60	12.86	18.76	--	--
Asset Turnover	0.75	0.81	0.83	1.22	--	--
Receivable days	104.89	69.43	62.37	68.49	--	--
Inventory Days	74.24	52.40	43.36	24.84	--	--
Payable days	142.32	105.74	97.57	59.40	--	--
Cash Conversion Cycle	36.81	16.09	8.16	33.92	--	--